Sort
11,323 grants matching “glioblastoma”
Time-reversal acoustic device for enhanced drug delivery for brain gliomas
$364,072Armen Sarvazyan · Artann Laboratories, Inc. · R43 · FY2009 · NS
High-dimensional unsupervised learning, with applications to genomics
$364,050Daniela Witten · University Of Washington · DP5 · FY2015 · OD
Role of RBBP4/p300 Complex in Recovery from therapy induced DNA damage in glioblastoma
$364,031Gaspar Julius Kitange · Mayo Clinic Rochester · R01 · FY2020 · CA
Interaction between Tissue Factor, Junctional Adhesion Molecule-A, and Integrin B1 to drive self-renewal in glioblastoma
$363,946Craig Michael Horbinski · Northwestern University At Chicago · R01 · FY2022 · NS
Bioinformatic Tools in Cancer Research
$363,916Kenneth H Buetow · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Engineered and Encapsulated Stem Cells for Resected Brain Tumors
$363,913Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2023 · NS
Engineered and Encapsulated Stem Cells for Resected Brain Tumors
$363,913Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2022 · NS
Defining Therapeutic Paradigms Based on Molecular Profiling of GBM
$363,905Brian D. Ross · University Of Michigan At Ann Arbor · P01 · FY2013 · CA
Elucidating the Role of Perivascular Niche in Glioblastoma Invasion and Therapeutic Resistance at Single Cell Resolution using Biomimetic Tumor Microenvironment Models
$363,880Mehdi Nikkhah · Arizona State University-Tempe Campus · R01 · FY2024 · NS
High-dimensional unsupervised learning, with applications to genomics
$363,800Daniela Witten · University Of Washington · DP5 · FY2014 · OD
Project 1: Modeling tumor evolution in mouse and organoid models
$363,795Raul Rabadan · Columbia University Health Sciences · U54 · FY2016 · CA
Nanoparticle Modified Human Fat Derived Mesenchymal Stem Cells for Brain Cancer (Change of Organization Application)
$363,722Alfredo Quinones-Hinojosa · Mayo Clinic Jacksonville · R01 · FY2020 · CA
Regulation of Necroptosis and inflammation
$363,713Zhenkun Lou · Mayo Clinic Rochester · R01 · FY2021 · CA
Monocyte promotion of therapy resistance by immune and non-immune mechanisms
$363,713Yi Lin · Mayo Clinic Rochester · R01 · FY2016 · CA
Monocyte promotion of therapy resistance by immune and non-immune mechanisms
$363,713Yi Lin · Mayo Clinic Rochester · R01 · FY2017 · CA
Monocyte promotion of therapy resistance by immune and non-immune mechanisms
$363,713Yi Lin · Mayo Clinic Rochester · R01 · FY2020 · CA
Regulation of Necroptosis and inflammation
$363,713Zhenkun Lou · Mayo Clinic Rochester · R01 · FY2020 · CA
Development of B-cell-based vaccine for Glioblastoma
$363,713Catalina Lee Chang · Northwestern University At Chicago · R37 · FY2021 · CA
Monocyte promotion of therapy resistance by immune and non-immune mechanisms
$363,713Yi Lin · Mayo Clinic Rochester · R01 · FY2018 · CA
Regulation of Necroptosis and inflammation
$363,713Zhenkun Lou · Mayo Clinic Rochester · R01 · FY2019 · CA
Project 4- Targeting the neuronal microenvironment in gliomas (Monje/Suva)
$363,681Mario Luca Suva · Brigham And Women'S Hospital · P50 · FY2019 · CA
Project 4: Novel epigenetic treatment of IDH mutant gliomas
$363,680Harley I Kornblum · University Of California Los Angeles · P50 · FY2017 · CA
Nanoparticle Modified Human Fat Derived Mesenchymal Stem Cells for Brain Cancer (Change of Organization Application)
$363,623Alfredo Quinones-Hinojosa · Mayo Clinic Jacksonville · R01 · FY2018 · CA
Project 3: A New Therapeutic Target for TERT Promoter Mutant Glioma
$363,524Joseph F Costello · University Of California, San Francisco · P50 · FY2020 · CA
Identification and Characterization of Kinase Oncogenes in Glioblastoma
$363,477Lynda Chin · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA